Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and Processes
Open Access
- 24 April 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 10, 320
Abstract
Clear cell renal cell carcinoma (ccRCC) is the third most common urological cancer, and it has the highest mortality rate. The increasing drug resistance of metastatic ccRCC has resulted in the search for new biomarkers. Epigenetic regulatory mechanisms, such as genome-wide DNA methylation and inhibition of protein translation by interaction of microRNA (miRNA) with its target messenger RNA (mRNA), are deeply involved in the pathogenesis of human cancers, including ccRCC, and may be used in its diagnosis and prognosis. Here, we review oncogenic and oncosuppressive miRNAs, their putative target genes, and the crucial pathways they are involved in. The contradictory behavior of a number of miRNAs, such as suppressive and anti-metastatic miRNAs with oncogenic potential (for example, miR-99a, miR-106a, miR-125b, miR-144, miR-203, miR-378), is examined. miRNAs that contribute mostly to important pathways and processes in ccRCC, for instance, PI3K/AKT/mTOR, Wnt-β, histone modification, and chromatin remodeling, are discussed in detail. We also separately consider their participation in crucial oncogenic processes, such as hypoxia and angiogenesis, metastasis, and epithelial-mesenchymal transition (EMT). The review also considers the interactions of long non-coding RNAs (lncRNAs) and miRNAs of significance in ccRCC. Recent advances in the understanding of the role of hypermethylated miRNA genes in ccRCC and their usefulness as biomarkers are reviewed based on our own data and those available in the literature. Finally, new data and perspectives concerning the clinical applications of miRNAs in the diagnosis, prognosis, and treatment of ccRCC are discussed.Keywords
This publication has 213 references indexed in Scilit:
- Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinomaBMC Cancer, 2014
- Inhibition of PTEN Gene Expression by Oncogenic miR-23b-3p in Renal CancerPLOS ONE, 2012
- MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinomaBMC Cancer, 2012
- Renal cancer biomarkers: the promise of personalized careBMC Medicine, 2012
- VHL-Regulated MiR-204 Suppresses Tumor Growth through Inhibition of LC3B-Mediated Autophagy in Renal Clear Cell CarcinomaCancer Cell, 2012
- Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinomaJournal of Translational Medicine, 2012
- MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinomaCarcinogenesis, 2011
- DNA methylation-associated silencing of tumor-suppressor microRNAs in cancerOncogene, 2011
- MicroRNAs and their target gene networks in renal cell carcinomaBiochemical and Biophysical Research Communications, 2011
- The VHL-dependent regulation of microRNAs in renal cancerBMC Medicine, 2010